Plus Therapeutics Analyst Ratings
Plus Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 220% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 08/14/2023 | 220% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/30/2023 | 220% | HC Wainwright & Co. | $3.5 → $8 | Maintains | Buy |
| 05/03/2023 | 380% | Maxim Group | $30 → $12 | Maintains | Buy |
| 04/21/2023 | 40% | HC Wainwright & Co. | → $3.5 | Reiterates | → Buy |
| 02/27/2023 | 40% | HC Wainwright & Co. | → $3.5 | Reiterates | → Buy |
| 10/07/2022 | 100% | JonesTrading | → $5 | Initiates Coverage On | → Buy |
| 07/22/2022 | 40% | HC Wainwright & Co. | $7 → $3.5 | Maintains | Buy |
| 02/11/2021 | 180% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 01/25/2021 | 220% | Ladenburg Thalmann | → $8 | Initiates Coverage On | → Buy |
| 10/16/2020 | 140% | Maxim Group | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月15日 | 220% | HC Wainwright公司 | →$8 | 重申 | 购买→购买 |
| 2023年08月14日 | 220% | HC Wainwright公司 | →$8 | 重申 | 购买→购买 |
| 2023/06/30 | 220% | HC Wainwright公司 | $3.5→$8 | 维护 | 买 |
| 05/03/2023 | 380% | Maxim集团 | $30→$12 | 维护 | 买 |
| 04/21/2023 | 40% | HC Wainwright公司 | →$3.5 | 重申 | →购买 |
| 02/27/2023 | 40% | HC Wainwright公司 | →$3.5 | 重申 | →购买 |
| 10/07/2022 | 100% | Jones Trading | →$5 | 开始承保 | →购买 |
| 07/22/2022 | 40% | HC Wainwright公司 | $7→$3.5 | 维护 | 买 |
| 02/11/2021 | 180% | HC Wainwright公司 | →$7 | 开始承保 | →购买 |
| 2021/01/25 | 220% | 拉登堡·塔尔曼 | →$8 | 开始承保 | →购买 |
| 10/16/2020 | 140% | Maxim集团 | →$6 | 开始承保 | →购买 |
What is the target price for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的目标价格是多少？
The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $8.00 expecting PSTV to rise to within 12 months (a possible 220.00% upside). 7 analyst firms have reported ratings in the last year.
2023年8月15日，HC Wainwright&Co.报道了Plus治疗公司(纳斯达克：PSTV)的最新目标价。这家分析公司将目标价定为8美元，预计PSTV将在12个月内上涨(可能上涨220.00%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的最新分析师评级是什么？
The latest analyst rating for Plus Therapeutics (NASDAQ: PSTV) was provided by HC Wainwright & Co., and Plus Therapeutics reiterated their buy rating.
普洛斯治疗公司(纳斯达克代码：PSTV)的最新分析师评级是由HC Wainwright&Co.提供的，普洛斯治疗公司重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Plus Therapeutics (PSTV)?
Plus Treeutics(PSTV)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Plus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Plus Therapeutics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Plus Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Plus治疗公司的上一次评级是在2023年8月15日提交的，所以你应该预计下一次评级将在2024年8月15日左右提供。
Is the Analyst Rating Plus Therapeutics (PSTV) correct?
分析师评级加治疗(PSTV)正确吗？
While ratings are subjective and will change, the latest Plus Therapeutics (PSTV) rating was a reiterated with a price target of $0.00 to $8.00. The current price Plus Therapeutics (PSTV) is trading at is $2.50, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Plus治疗(PSTV)评级被重申，目标价在0.00美元至8.00美元之间。目前Plus Treateutics(PSTV)的交易价格为2.50美元，在分析师的预测范围内。